Načítá se...
Engineering trypsin for inhibitor resistance
The development of effective protease therapeutics requires that the proteases be more resistant to naturally occurring inhibitors while maintaining catalytic activity. A key step in developing inhibitor resistance is the identification of key residues in protease-inhibitor interaction. Given that m...
Uloženo v:
| Vydáno v: | Protein Sci |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570540/ https://ncbi.nlm.nih.gov/pubmed/26106067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pro.2732 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|